PRESENDIN
LIVE

Serial Number

79297231

Owner

Invex Therapeutics Ltd

Filing Date

Aug 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PRESENDIN Trademark

Serial Number: 79297231 • Registration: 6317927

PRESENDIN is a trademark filed by Invex Therapeutics Ltd on August 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Invex Therapeutics Ltd

Birmingham Research Park,

Entity Type: 24

Trademark Details

Filing Date

August 21, 2020

Registration Date

April 13, 2021

Published for Opposition

January 26, 2021

Goods & Services

Pharmaceutical preparations for the treatment of increased intracranial pressure (ICP) and intracranial hypertension; pharmaceutical preparations for the treatment of glaucoma, stroke, brain injury and aneurysm

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 11, 2022 NREP
NOTIFICATION PROCESSED BY IB
Jun 6, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 14, 2021 FICS
FINAL DISPOSITION PROCESSED
May 14, 2021 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 13, 2021 GPAR
REGISTERED-PRINCIPAL REGISTER
Apr 13, 2021 R.PR
PUBLISHED FOR OPPOSITION
Jan 26, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Jan 24, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 6, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 6, 2021 OP2R
NOTICE OF PUBLICATION
Jan 6, 2021 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2020 CNSA
ASSIGNED TO EXAMINER
Dec 18, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 10, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 5, 2020 REPR